American Research & Management Company’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$30K Sell
1,278
-122
-9% -$3.68K 0.01% 228
2022
Q2
$47K Sell
1,400
-17
-1% -$595 0.01% 204
2022
Q1
$49K Sell
1,417
-97
-6% -$3.32K 0.01% 208
2021
Q4
$46K Sell
1,514
-148
-9% -$4.82K 0.01% 214
2021
Q3
$54K Sell
1,662
-304
-15% -$9.73K 0.01% 200
2021
Q2
$59K Buy
+1,966
New +$64.7K 0.01% 207

Other funds holding OGN

American Research & Management Company's OGN Position: Q3 2022 in Review

American Research & Management Company reduced its Organon & Co (OGN) stake by 8.7% in Q3 2022, selling an estimated $3.68K and leaving 1,278 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #228.

American Research & Management Company first reported a position in OGN in Q2 2021 and has held it in 6 quarters since. The position peaked at $59K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • American Research & Management Company held 1,278 shares of Organon & Co worth $30K as of Q3 2022.
  • American Research & Management Company sold 122 Organon & Co shares in Q3 2022, an estimated $3.68K.
  • Organon & Co made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #228 holding.
  • American Research & Management Company first reported a position in Organon & Co in Q2 2021 and has held it in 6 quarters since.
  • American Research & Management Company's Organon & Co position peaked at $59K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.